Publication | Closed Access

A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models

VaccinationNew VaccineDiabetes DevelopmentVaccine DevelopmentVaccine TargetImmunologyViral PathogenesisVirologyMouse ModelsVirus-host InteractionMedicineVaccine Research